These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 25914465

  • 1. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD, Zuo Y, Xu Z, Zhang M.
    World J Gastroenterol; 2015 Apr 21; 21(15):4564-73. PubMed ID: 25914465
    [Abstract] [Full Text] [Related]

  • 2. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu W, Xu Z, Zhang M, Zuo Y.
    Int J Clin Exp Pathol; 2014 Apr 21; 7(10):7286-96. PubMed ID: 25400827
    [Abstract] [Full Text] [Related]

  • 3. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH, Wang HB.
    J Cell Physiol; 2019 Aug 21; 234(10):18587-18601. PubMed ID: 30953349
    [Abstract] [Full Text] [Related]

  • 4. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L, Yin J, Wang X, Shao M, Duan F, Wu W, Peng P, Jin J, Tang Y, Ruan Y, Sun Y, Gu J.
    Gastroenterology; 2016 May 21; 150(5):1183-1195.e16. PubMed ID: 26855187
    [Abstract] [Full Text] [Related]

  • 5. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
    Zheng YB, Xiao GC, Tong SL, Ding Y, Wang QS, Li SB, Hao ZN.
    World J Gastroenterol; 2015 Jun 21; 21(23):7197-207. PubMed ID: 26109806
    [Abstract] [Full Text] [Related]

  • 6. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y, Ge Y, Jiang M, Zhou J, Luo D, Fan H, Shi L, Lin L, Yang L.
    Cell Physiol Biochem; 2018 Jun 21; 47(4):1465-1481. PubMed ID: 29949784
    [Abstract] [Full Text] [Related]

  • 7. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J, Huang J, Xu J, Huang Q, Wang J, Zhong W, Lin X, Li Y, Lin X.
    BMC Cancer; 2017 Sep 06; 17(1):626. PubMed ID: 28874138
    [Abstract] [Full Text] [Related]

  • 8. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma H, Xia J, Bin J, Liao Y, Liao W.
    Oncotarget; 2015 Jun 20; 6(17):15222-34. PubMed ID: 25945841
    [Abstract] [Full Text] [Related]

  • 9. The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer.
    Yu WW, Jiang H, Zhang CT, Peng Y.
    Oncotarget; 2017 Jun 13; 8(24):39280-39295. PubMed ID: 28424413
    [Abstract] [Full Text] [Related]

  • 10. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling.
    Xu SH, Huang JZ, Xu ML, Yu G, Yin XF, Chen D, Yan GR.
    J Pathol; 2015 Jun 13; 236(2):175-85. PubMed ID: 25678401
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Xu M, Qin S, Cao F, Ding S, Li M.
    Int J Oncol; 2017 Sep 13; 51(3):867-876. PubMed ID: 28713929
    [Abstract] [Full Text] [Related]

  • 12. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
    Jiang K, Xie LF, Xiao TZ, Qiu MY, Wang WL.
    Eur Rev Med Pharmacol Sci; 2019 Oct 13; 23(20):8861-8869. PubMed ID: 31696473
    [Abstract] [Full Text] [Related]

  • 13. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C, Tao Y, Gao Y, Xia Y, Liu Y, Wang G, Gu Y.
    Biomed Pharmacother; 2018 Feb 13; 98():416-423. PubMed ID: 29278851
    [Abstract] [Full Text] [Related]

  • 14. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
    Liu Z, Zhu J, Cao H, Ren H, Fang X.
    Int J Oncol; 2012 May 13; 40(5):1553-60. PubMed ID: 22293682
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
    Zhang P, Tang WM, Zhang H, Li YQ, Peng Y, Wang J, Liu GN, Huang XT, Zhao JJ, Li G, Li AM, Bai Y, Chen Y, Ren YX, Li GX, Wang YD, Liu SD, Wang JD.
    Br J Cancer; 2017 Aug 08; 117(4):525-534. PubMed ID: 28632723
    [Abstract] [Full Text] [Related]

  • 18. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
    Wei S, Wang L, Zhang L, Li B, Li Z, Zhang Q, Wang J, Chen L, Sun G, Li Q, Xu H, Zhang D, Xu Z.
    Tumour Biol; 2016 Sep 08; 37(9):12813-12821. PubMed ID: 27449034
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer.
    Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu Z, Tang W, Gan L, Sun M, Li J.
    Oncotarget; 2015 Sep 22; 6(28):25418-28. PubMed ID: 26317898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.